Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenoprotein synthesis" does not refer to a single molecule, receptor, or protein, but rather to a multistep biochemical pathway responsible for the incorporation of the amino acid selenocysteine (Sec) into selenoproteins during translation[5][2][3]. This pathway involves specific translational machinery, including the SECIS element in mRNA, SECIS-binding protein 2 (SBP2), a specialized tRNA (tRNA[Ser]Sec), selenocysteine synthase (SecS), selenophosphate synthetase, and unique elongation factors[1][3]. The process is essential for the synthesis of all selenoproteins, which play roles in antioxidant defense, thyroid function, and cellular homeostasis[2][4]. Defects in elements of selenoprotein synthesis are linked to diseases such as progressive cerebello-cerebral atrophy and metabolic syndromes[2]. Because it represents a biological process and not a druggable protein or receptor, "selenoprotein synthesis" is not considered a therapeutic target in the conventional sense[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein synthesis.